Activated ADI pathway: the initiator of intermediate vancomycin resistance in Staphylococcus aureus

Comparative proteomic profiling between 2 vancomycin-intermediate Staphylococcus aureus (VISA) strains, Mu50Ω-vraSm and Mu50Ω-vraSm-graRm, and vancomycin-susceptible S. aureus (VSSA) strain Mu50Ω revealed upregulated levels of catabolic ornithine carbamoyltransferase (ArcB) of the arginine catabolis...

Full description

Saved in:
Bibliographic Details
Published inCanadian journal of microbiology Vol. 63; no. 3; pp. 260 - 264
Main Authors Tan, Xin-Ee, Neoh, Hui-min, Looi, Mee-Lee, Chin, Siok Fong, Cui, Longzhu, Hiramatsu, Keiichi, Hussin, Salasawati, Jamal, Rahman
Format Journal Article
LanguageEnglish
Published Canada NRC Research Press 01.03.2017
Canadian Science Publishing NRC Research Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Comparative proteomic profiling between 2 vancomycin-intermediate Staphylococcus aureus (VISA) strains, Mu50Ω-vraSm and Mu50Ω-vraSm-graRm, and vancomycin-susceptible S. aureus (VSSA) strain Mu50Ω revealed upregulated levels of catabolic ornithine carbamoyltransferase (ArcB) of the arginine catabolism pathway in VISA strains. Subsequent analyses showed that the VISA strains have higher levels of cellular ATP and ammonia, which are by-products of arginine catabolism, and displayed thicker cell walls. We postulate that elevated cytoplasmic ammonia and ATP molecules, resulting from activated arginine catabolism upon acquisition of vraS and graR mutations, are important requirements facilitating cell wall biosynthesis, thereby contributing to thickened cell wall and consequently reduced vancomycin susceptibility in VISA strains.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0008-4166
1480-3275
DOI:10.1139/cjm-2016-0439